Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer
Clinical trial NCT00592007 · TERMINATED
Trial details
- NCT number
- NCT00592007
- Sponsor
- Lyudmila Bazhenova, M.D.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2012-01-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.